Co-Authors
This is a "connection" page, showing publications co-authored by Michael Yost and Joshua Rhett.
Connection Strength
2.108
-
Mechanism of action of the anti-inflammatory connexin43 mimetic peptide JM2. Am J Physiol Cell Physiol. 2017 Sep 01; 313(3):C314-C326.
Score: 0.602
-
Connexin-Based Therapeutics and Tissue Engineering Approaches to the Amelioration of Chronic Pancreatitis and Type I Diabetes: Construction and Characterization of a Novel Prevascularized Bioartificial Pancreas. J Diabetes Res. 2016; 2016:7262680.
Score: 0.540
-
Purinergic signaling in early inflammatory events of the foreign body response: modulating extracellular ATP as an enabling technology for engineered implants and tissues. Tissue Eng Part B Rev. 2014 Oct; 20(5):392-402.
Score: 0.473
-
Inhibition of connexin 43 hemichannel-mediated ATP release attenuates early inflammation during the foreign body response. Tissue Eng Part A. 2015 Jun; 21(11-12):1752-62.
Score: 0.257
-
Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology. J Vis Exp. 2018 03 27; (133).
Score: 0.158
-
Novel therapies for scar reduction and regenerative healing of skin wounds. Trends Biotechnol. 2008 Apr; 26(4):173-80.
Score: 0.079